COVID-19: Nanomix Wins BARDA Funding For Mobile Point-Of-Care Assay

 
• By Reed Miller

The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.

Grants / Project Funding / Grant Application
• Source: shutterstock.com

More from In Vitro Diagnostics

More from Diagnostics